MODALITY
saveCAR-T
T cells engineered with chimeric antigen receptors.
also known as: cart, chimeric antigen receptor t-cell
drugs
0
catalysts
0
news
9
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and moreendpoints · 2mo ago
- STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2Bstat · 2mo ago
- A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scriptsstat · 2mo ago
comments(0)
5-min edit window · permanent after that